For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Diadexus, Inc.

USPTO Granted Patents = 47

CIPO Patents = 2

EPO Patents = 5

Trademarks = 2

Forward Citations = 605

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Yongming Sun (23 out of 23 patents)

Herve Recipon (19 out of 19 patents)

Roberto A Macina (15 out of 15 patents)

4. Susana Salceda (14 out of 14 patents)

5. Robert Cafferkey (14 out of 14 patents)

6. Jackie Papkoff (8 out of 10 patents)

7. Laura Corral (7 out of 8 patents)

8. Iris Simon (6 out of 7 patents)

9. Glenn Ronald Pilkington (6 out of 8 patents)

10. Shujath Ali (6 out of 6 patents)

11. Chenghua Liu (5 out of 17 patents)

12. Gilbert-Andre Keller (4 out of 6 patents)

13. Wenlu Li (4 out of 4 patents)

14. Gundo Diedrich (3 out of 8 patents)

15. Shu-Hui Liu (3 out of 16 patents)

Core Competencies:

Lipoprotein-Associated Phospholipase A2

Ovarian Specific Genes

Prostate Cancer

Breast Cancer

Colorectal Cancer

Lung Cancer

Cancer Risk Assessment

Antibody Compositions

Gynecologic Cancers

Gastrointestinal Cancers

Cancer Monitoring

Cancer Imaging

47 patents: Sort by Forward Citations

1. 9000132 - Lipoprotein-associated phospholipase A2 antibody compositions and methods of use (2015-04-07),

2. 8906369 - Ovr110 antibody compositions and methods of use (2014-12-09),

3. 8460880 - Compositions, splice variants and methods relating to ovarian specific genes and proteins (2013-06-11),

4. 8444971 - OVR110 antibody compositions and methods of use (2013-05-21),

5. 8354508 - PRO115 antibody compositions and methods of use (2013-01-15),

6. 8287867 - Ovr115 antibody compositions and methods of use (2012-10-16),

7. 8207311 - Ovr115 antibody compositions and methods of use (2012-06-26),

8. 8173434 - PCan065 antibody compositions and methods of use (2012-05-08),

9. 8148093 - Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk (2012-04-03),

10. 8080650 - Pro104 antibody compositions and methods of use (2011-12-20),

11. 8029787 - Method of diagnosing, monitoring, staging, imaging and treating various cancers (2011-10-04),

12. 7964195 - Ovr110 antibody compositions and methods of use (2011-06-21),

13. 7858325 - Method of diagnosing, monitoring, staging, imaging and treating prostate cancer (2010-12-28),

14. 7737255 - Method of diagnosing, monitoring, staging, imaging and treating various cancers (2010-06-15),

15. 7678889 - Compositions and methods relating to ovarian specific genes and proteins (2010-03-16),

diaDexus, Inc. is a biotechnology company focused on the development and commercialization of innovative diagnostic products to improve patient care. With a strong emphasis on cardiovascular diseases, the company's products enable healthcare professionals to efficiently identify patients at risk and make informed treatment decisions. diaDexus is dedicated to advancing precision medicine through its molecular and immunoassay-based tests. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

47 Patents

#34 in South San Francisco, CA

#1,712 in California

#7,183 in US

#14,401 in the World

South San Francisco, CA, United States of America

Diadexus, Inc.

Forward Citations = 605

44 inventors:

Yongming Sun (23 out of 23 patents)

Herve Recipon (19 out of 19 patents)

Roberto A Macina (15 out of 15 patents)

4. Susana Salceda (14 out of 14 patents)

5. Robert Cafferkey (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…